Used to address oncology care, this generic medicine modulates systemic immune responses and suppresses the development of irregular cell growth pathways within the body.
Intended to relieve multiple myeloma proliferation to support clinical remission and target neoplastic pathways.
Mechanism of Action
Inhibits basic TNF-alpha synthesis, blocks tumor cell division, and prevents angiogenesis within neoplastic structures.
Route of Administration
Oral
Onset Time
2–4 weeks
Duration
24 hours
Contraindications
Pregnancy, Hypersensitivity to thalidomide
Severe Adverse Events
Phocomelia — requires immediate medical attention, Deep vein thrombosis — requires immediate medical attention, Severe peripheral neuropathy — requires immediate medical attention
Common Side Effects
Constipation, Fatigue, Headache
Uncommon Side Effects
Somnolence, Peripheral neuropathy, Dry skin
Drug Interactions
Dexamethasone, Anticoagulants
Pregnancy Safety Warnings
TGA Category X: Highly teratogenic. Avoid any exposure. Use strict contraception protocols. Breastfeeding: Contraindicated.
Information related to Thalix is compiled and periodically reviewed with reference to established medical sources and prescribing guidance. Content is provided for general reference and should be confirmed with a registered healthcare professional before use.
